Better biomarkers
New funding will help Seaside Therapeutics, a Massachusetts-based company, develop biomarkers to track the success of treatments for autism, says Aileen Healy.
New funding will help Seaside Therapeutics, a Massachusetts-based company, develop biomarkers to track the success of treatments for autism, says Aileen Healy.